NO20071253L - Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer. - Google Patents

Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer.

Info

Publication number
NO20071253L
NO20071253L NO20071253A NO20071253A NO20071253L NO 20071253 L NO20071253 L NO 20071253L NO 20071253 A NO20071253 A NO 20071253A NO 20071253 A NO20071253 A NO 20071253A NO 20071253 L NO20071253 L NO 20071253L
Authority
NO
Norway
Prior art keywords
synthesis
substituted
cpla2 inhibitors
indoles useful
compound
Prior art date
Application number
NO20071253A
Other languages
English (en)
Norwegian (no)
Inventor
Panolil Raveendranath
Ronald Stanley Michalak
Mahmut Levent
Frederick J Vyverberg
Ara R Boyajian
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20071253L publication Critical patent/NO20071253L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/14Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20071253A 2004-08-19 2007-03-07 Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer. NO20071253L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60312404P 2004-08-19 2004-08-19
PCT/US2005/029338 WO2006023611A1 (fr) 2004-08-19 2005-08-18 Procede de synthese d’indoles n-alkyles substitues en c-2, c-3 utiles comme inhibiteurs de la cpla2

Publications (1)

Publication Number Publication Date
NO20071253L true NO20071253L (no) 2007-05-15

Family

ID=35219553

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071253A NO20071253L (no) 2004-08-19 2007-03-07 Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer.

Country Status (24)

Country Link
US (3) US7582772B2 (fr)
EP (1) EP1778629B1 (fr)
JP (1) JP2008510707A (fr)
KR (1) KR20070043036A (fr)
CN (2) CN101006048B (fr)
AR (1) AR053410A1 (fr)
AT (1) ATE517084T1 (fr)
AU (1) AU2005277392A1 (fr)
BR (1) BRPI0514431A (fr)
CA (1) CA2576008A1 (fr)
CR (1) CR8936A (fr)
EC (1) ECSP077244A (fr)
GT (1) GT200500224A (fr)
HN (1) HN2005000474A (fr)
IL (1) IL181364A0 (fr)
MX (1) MX2007002042A (fr)
NO (1) NO20071253L (fr)
PE (1) PE20060628A1 (fr)
RU (1) RU2401829C2 (fr)
SG (1) SG155214A1 (fr)
SV (1) SV2006002200A (fr)
TW (1) TW200609214A (fr)
UA (1) UA85428C2 (fr)
WO (1) WO2006023611A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713964B2 (en) * 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US7342119B2 (en) * 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
HN2004000536A (es) 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
TW200718687A (en) * 2005-05-27 2007-05-16 Wyeth Corp Inhibitors of cytosolic phospholipase A2
BRPI0718042A2 (pt) * 2006-10-31 2013-11-12 Wyeth Corp Formulações semissólidas de inibidores de enzima fosfolipase
CL2007003143A1 (es) * 2006-10-31 2008-01-25 Wyeth Corp Composicion farmaceutica que comprende un compuesto derivado de indol y un sistema portador que comprende 10-50% de un primer solubilizante, 5-50% de un segundo solubilizante, 10-30% de un primer diluyente y 1-15% de un segundo diluyente; proceso de prepracion; y forma de dosificacion.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02115157A (ja) * 1988-10-24 1990-04-27 Hokko Chem Ind Co Ltd スルホニルグリシン誘導体および除草剤
BR0016739A (pt) * 1999-12-09 2002-09-03 Aventis Cropscience Gmbh Nitro-sulfobenzamidas
US7101875B2 (en) * 2001-12-03 2006-09-05 Wyeth Methods for treating arthritic disorders
US6635771B2 (en) * 2001-12-03 2003-10-21 Wyeth N-benzhydryl indole compounds
DK1451154T3 (da) * 2001-12-03 2008-05-19 Wyeth Corp Inhibitorer af cytosolisk phospholipase A2
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US6984735B2 (en) * 2001-12-03 2006-01-10 Wyeth Process for making an aldehyde
US6797708B2 (en) * 2001-12-03 2004-09-28 Wyeth Inhibitors of cytosolic phospholipase A2
US7713964B2 (en) * 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
TW200510305A (en) * 2003-07-25 2005-03-16 Wyeth Corp Process for the preparation of CPLA2 inhibitors
KR20060059977A (ko) 2003-07-29 2006-06-02 시바 스폐셜티 케미칼스 홀딩 인코포레이티드 3-아릴-2-시아노-3-히드록시-아크릴산 유도체
US7582771B2 (en) * 2003-09-03 2009-09-01 Wyeth Process for the synthesis of cPLA2 inhibitors
US7342119B2 (en) * 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
HN2004000536A (es) * 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles

Also Published As

Publication number Publication date
CA2576008A1 (fr) 2006-03-02
RU2007105231A (ru) 2008-09-27
US20060041005A1 (en) 2006-02-23
RU2401829C2 (ru) 2010-10-20
EP1778629B1 (fr) 2011-07-20
SG155214A1 (en) 2009-09-30
CR8936A (es) 2007-04-26
CN101830837A (zh) 2010-09-15
ATE517084T1 (de) 2011-08-15
KR20070043036A (ko) 2007-04-24
BRPI0514431A (pt) 2008-06-10
ECSP077244A (es) 2007-03-29
WO2006023611A1 (fr) 2006-03-02
TW200609214A (en) 2006-03-16
HN2005000474A (es) 2009-04-07
US7582772B2 (en) 2009-09-01
AU2005277392A1 (en) 2006-03-02
CN101006048B (zh) 2011-07-06
US20090306428A1 (en) 2009-12-10
GT200500224A (es) 2006-03-21
MX2007002042A (es) 2007-03-29
SV2006002200A (es) 2006-05-09
JP2008510707A (ja) 2008-04-10
PE20060628A1 (es) 2006-08-14
US7842837B2 (en) 2010-11-30
US8034960B2 (en) 2011-10-11
UA85428C2 (ru) 2009-01-26
EP1778629A1 (fr) 2007-05-02
US20110054189A1 (en) 2011-03-03
IL181364A0 (en) 2007-07-04
AR053410A1 (es) 2007-05-09
CN101006048A (zh) 2007-07-25

Similar Documents

Publication Publication Date Title
NO20080157L (no) Fremgangsmate for syntese av organiske forbindelser
NO20071253L (no) Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer.
MY136959A (en) Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
UA80834C2 (en) Method of synthesising ivabradine and the salts thereof for addition to a pharmaceutically acceptable acid
TW200624421A (en) Method for preparing n-phenylpyrazole-1-carboxamides
PT1725537E (pt) Novos compostos como moduladores do receptor opióide
NO20074055L (no) Prosesser for a fremstille 4-(fenoksy-5-metylpyrimidin-4-yloksy)piperidin-1-karboksylsyrederivater og relaterte forbindelser
NO20082243L (no) Fremgangsmater og forbindelser for fremstiliing av CC-1065 analoger
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
TW200630363A (en) Process for preparing trisubstituted pyrimidine compounds
NO20054669L (no) Substituerte kinobenzoxazinanaloger
EA200600485A1 (ru) Способ получения производных 2-оксо-1-пирролидина
NO20060142L (no) Syklisk tertiaer aminforbindelse
WO2005000804A3 (fr) Indoles substitues et procede de preparation d'indoles substitues
DK1303514T3 (da) Fremgangsmåde til fremstilling af azacycloalkanoylaminothiazoler
NO20062936L (no) Fremgangsmate for fremstilling av N-alkyl-2(hydroksy-4-benzoyl)-3-benzofuraner og dets mellomprodukter derav
NO20070972L (no) Benzyloksyderivater som MAOB-inhibitorer
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
PT1893589E (pt) Derivados substituídos de n-benzo[d]isoxazol-3-il-amina como inibidores de recetores mglur5, recetores de serotonina-(5-ht) e recetores de noradrenalina e sua utilização na produção de medicamentos
NO20062152L (no) Fremstilling av 3-azabicyklo [3.1.0.]heksanderivater
TW200616997A (en) The preparation method for 6-substituted-1-methyl-1h-benzoimidazol derivatives and their preparation imtermediates
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
TR200401488T4 (tr) CNS bozukluklarının tedavisinde faydalı indol türevleri
TW200619201A (en) Process for the preparation of pyrazoles
EA200801123A1 (ru) Производные 6-гетероарилпиридоиндолона, способ их получения и применение их в терапии

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application